IL-4Rα signaling promotes barrier-altering oncostatin M and IL-6 production in aspirin-exacerbated respiratory disease.
Chen CC, Buchheit KM, Lee PY, Brodeur KE, Sohail A, Cho L, Baloh C, Balestrieri B, Derakhshan M, Feng C, Boyce JA, Dwyer D, Laidlaw TM.
Chen CC, et al. Among authors: feng c.
J Allergy Clin Immunol. 2024 May 2:S0091-6749(24)00453-6. doi: 10.1016/j.jaci.2024.04.020. Online ahead of print.
J Allergy Clin Immunol. 2024.
PMID: 38704098